OpGen, Inc. (LON: 0A8L)
London flag London · Delayed Price · Currency is GBP · Price in USD
1.560
0.00 (0.00%)
At close: Jan 21, 2025

OpGen Company Description

OpGen, Inc., a precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally.

The company’s products include Unyvero application cartridges, Unyvero systems, Acuitas AMR Gene Panel test products, and SARS CoV-2 test kits.

It provides laboratory services; collaboration services, including funded software arrangements; and license arrangements services.

OpGen, Inc. was incorporated in 2001 and is headquartered in Rockville, Maryland.

OpGen, Inc.
Country United States
Founded 2001
Industry In Vitro and In Vivo Diagnostic Substances
Employees 93
CEO Honjian Tan

Contact Details

Address:
9717 Key West Avenue
Rockville, Delaware 20850
United States
Phone 240 813 1260
Website opgen.com

Stock Details

Ticker Symbol 0A8L
Exchange London Stock Exchange
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
SIC Code 2835

Key Executives

Name Position
Honjian Tan Chief Executive Officer
David Caplon Chief Financial Officer
Mohd Azudin Chief Operating Officer